


An Early Out Under § 101 Based on Claimed Long-standing Commercial Practices

Done at Step 1: When a Claim Is Tied to an Improvement, No Need to Proceed to Alice Step 2

Fishing for Eligibility in Murky Waters

Yet Another Pharmaceutical Patent Falls Under the Scrutiny of 35 U.S.C. § 112

The Risk of Using “Consisting Essentially of” in Patent Claims

For the First Time, a Medical Treatment Patent Is Ruled Invalid Under Mayo/Myriad

A Morass of Possible Combinations Does Not Satisfy the Written Description Requirement under 35 U.S.C. § 112
Subscribe: Subscribe via RSS
Blogs
Firm/Org